Tonix Pharmaceuticals Holding Corp.
TNXP
$13.22
$1.2410.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 27.61% | 63.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 27.61% | 63.83% | |||
| Cost of Revenue | 49.15% | -22.60% | |||
| Gross Profit | 22.35% | 125.27% | |||
| SG&A Expenses | -19.77% | 38.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.80% | 47.64% | |||
| Operating Income | 13.98% | -46.02% | |||
| Income Before Tax | 14.32% | -46.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.32% | -46.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.32% | -46.55% | |||
| EBIT | 13.98% | -46.02% | |||
| EBITDA | 14.26% | -46.59% | |||
| EPS Basic | 26.25% | -10.83% | |||
| Normalized Basic EPS | 26.25% | -10.82% | |||
| EPS Diluted | 26.25% | -10.83% | |||
| Normalized Diluted EPS | 26.25% | -10.82% | |||
| Average Basic Shares Outstanding | 16.17% | 32.23% | |||
| Average Diluted Shares Outstanding | 16.17% | 32.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||